Olema Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 6.84 M | $67.00 M | 0.00% | 8.00% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 6.79 M | $66.51 M | 0.44% | 7.95% |
| BVF INC/IL | 11/14/2025 | 5.30 M | $51.85 M | 0.00% | 6.19% |
| BLACKROCK, INC. | 11/12/2025 | 4.73 M | $46.27 M | 2.63% | 5.53% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 3.59 M | $35.09 M | 18.63% | 4.19% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 3.47 M | $33.97 M | 0.79% | 4.06% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 3.21 M | $31.41 M | 0.00% | 3.75% |
| VANGUARD GROUP INC | 11/07/2025 | 3.20 M | $31.30 M | -2.13% | 3.74% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 3.01 M | $29.49 M | 0.00% | 3.52% |
| WOODLINE PARTNERS LP | 11/14/2025 | 2.22 M | $21.71 M | -36.74% | 2.59% |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 11/14/2025 | 1.93 M | $18.90 M | 0.00% | 2.26% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.64 M | $16.02 M | -12.91% | 1.91% |
| MORGAN STANLEY | 11/14/2025 | 1.56 M | $15.23 M | 8.24% | 1.82% |
| VIVO CAPITAL, LLC | 11/14/2025 | 1.51 M | $14.74 M | 0.00% | 1.76% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.28 M | $12.49 M | -3.78% | 1.49% |
| CANDRIAM S.C.A. | 11/06/2025 | 1.25 M | $12.23 M | 46.95% | 1.46% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.24 M | $12.11 M | -27.59% | 1.45% |
| UBS GROUP AG | 11/13/2025 | 1.19 M | $11.66 M | -15.68% | 1.39% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 1.15 M | $11.23 M | -2.20% | 1.34% |
| STATE STREET CORP | 11/14/2025 | 1.09 M | $10.71 M | 3.96% | 1.28% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.06 M | $10.42 M | -11.81% | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 933.54 K | $9.14 M | 100.00% | 1.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 854.00 K | $8.36 M | 100.00% | 1.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 803.88 K | $7.87 M | 10.94% | 0.94% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 802.30 K | $7.85 M | 0.35% | 0.94% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 693.18 K | $6.79 M | 100.00% | 0.81% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 619.87 K | $6.07 M | 100.00% | 0.73% |
| PIER CAPITAL, LLC | 11/13/2025 | 524.25 K | $5.13 M | -32.01% | 0.61% |
| NORTHERN TRUST CORP | 11/14/2025 | 483.03 K | $4.73 M | -3.28% | 0.57% |
| HIGHVISTA STRATEGIES LLC | 11/14/2025 | 437.18 K | $4.28 M | 57.02% | 0.51% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 395.13 K | $3.87 M | -8.22% | 0.46% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 331.45 K | $3.24 M | -73.92% | 0.39% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 299.62 K | $2.93 M | 4,450.02% | 0.35% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 250.00 K | $2.45 M | 0.00% | 0.29% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 245.42 K | $2.40 M | 100.00% | 0.29% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2025 | 244.08 K | $2.39 M | -1.80% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 204.21 K | $2.00 M | -10.44% | 0.24% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 174.00 K | $1.70 M | 29.85% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 169.20 K | $1.66 M | 2.99% | 0.20% |
| ROYAL BANK OF CANADA | 11/14/2025 | 148.34 K | $1.45 M | 25.92% | 0.17% |
| NUVEEN, LLC | 11/12/2025 | 128.22 K | $1.26 M | 0.00% | 0.15% |
| INVESCO LTD. | 11/13/2025 | 124.63 K | $1.22 M | 55.93% | 0.15% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 121.34 K | $1.19 M | -6.90% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 112.28 K | $1.10 M | 20.60% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 109.53 K | $1.07 M | 18.41% | 0.13% |
| BARCLAYS PLC | 11/12/2025 | 104.62 K | $1.02 M | -32.86% | 0.12% |
| LPL FINANCIAL LLC | 11/12/2025 | 96.68 K | $946.45 K | 45.06% | 0.11% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11/14/2025 | 94.88 K | $928.91 K | -16.40% | 0.11% |
| DIADEMA PARTNERS LP | 11/14/2025 | 90.50 K | $886.00 K | 100.00% | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 90.10 K | $882.08 K | 53.23% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 153 institutional investors and hedge funds held shares of Olema Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 6.84 M
Paradigm Biocapital Advisors LP: 6.79 M
BVF INC/IL: 5.3 M
BlackRock, Inc.: 4.73 M
JANUS HENDERSON GROUP PLC: 3.59 M
Deep Track Capital, LP: 3.47 M
79.87% of Olema Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 74.21 M shares in the last 24 months. This purchase volume represents approximately $2.05 B in transactions.